Supplier
Sterling Vision, PC
Sterling Vision, PC was paid $1.95M by Medicaid between Jan 2018 and Nov 2024, across 20 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 42% of everything it billed.
33Billing provider infoSTERLING VISION, PC
EUGENE, OR 97401
EUGENE, OR 97401
33aNPI1902161946assigned 07/05/2012
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$1.95M
24GClaims41,751
24DCodes billed20
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,268 | $330K | |
| 2019 | 4,833 | $311K | |
| 2020 | 4,044 | $203K | |
| 2021 | 7,256 | $227K | |
| 2022 | 7,674 | $185K | |
| 2023 | 7,435 | $339K | |
| 2024incomplete | 6,241 | $353K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 42% | 1,327 | 841 | $825K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 12% | 4,846 | 3,434 | $229K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 9.6% | 1,750 | 1,696 | $188K |
| 67028 | Intravitreal injection of a pharmacologic agent | 8.2% | 5,019 | 3,231 | $160K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 6.9% | 2,435 | 2,257 | $135K |
| 92134 | 5.4% | 7,661 | 5,356 | $106K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 1,600 | 1,301 | $75K |
| J9035 | Injection, bevacizumab, 10 mg | 3.3% | 1,302 | 1,011 | $63K |
| 92015 | Determination of refractive state | 3.1% | 4,630 | 4,466 | $59K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.0% | 1,607 | 1,351 | $59K |
| J2778 | Injection, ranibizumab, 0.1 mg | 1.1% | 73 | 40 | $22K |
| V2020 | Frames, purchases | <1% | 2,959 | 2,683 | $10K |
8 more codes
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 2,620 | $4K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 46 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 28 | $3K |
| 92235 | <1% | 34 | $1K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 3,364 | $1K |
| 92250 | <1% | 56 | $1K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 44 | $633.75 |
| V2799 | Vision item or service, miscellaneous | <1% | 350 | $25.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEDWARDS, ALBERT (OWNER/PHYSICIAN)